Premier News

Global Compliance

Premier Research Names Ellen Teplitzky Chief Compliance Officer and SVP of Legal Affairs

Clinical Research: Phase 1 - Phase 4

Pursuing Parkinson’s Disease Gene Therapies: Strategies & Operational Requirements

Premier Research Expands Global Footprint With Acquisition of India-Based Cytespace

Clinical Research: Phase 1 - Phase 4

Pathways to Expedited Drug Development in the U.S. and Europe

Clinical Research: Phase 1 - Phase 4

Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose Escalation Studies, Upcoming Webinar

TORONTO (PRWEB) FEBRUARY 08, 2021 Phase 1 clinical trials aim to determine the maximum tolerated dose (MTD) of a new molecule with the goal of identifying a recommended Phase 2 dose (RP2D), often the MTD itself. Ideally, the RP2D would have adequate therapeutic effect to demonstrate preliminary signs of efficacy in Phase 2, but many...

Data Management & Biostatistics

Premier Research Vice President, Statistical Consulting, Recognized by AMSTAT for Black History Month

DURHAM, N.C., February 1, 2021 — Premier Research, the clinical research company that delivers outcome-focused insights which support sponsors in developing life-changing therapies, announced today that Abie Ekangaki, Ph.D., Vice President, Statistical Consulting, has been recognized by the American Statistical Association (AMSTAT) in celebration of Black History Month. Dr. Ekangaki is one of ten Black...